My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 276

    1.

    Quality of care for patients diagnosed with diabetes at screening.

    Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ.

    Diabetes Care. 2003 Feb;26(2):367-71.PMID: 12547864 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Impact of diabetes screening on quality of life.

    Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ.

    Diabetes Care. 2002 Jun;25(6):1022-6.PMID: 12032109 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Screening for diabetes in an outpatient clinic population.

    Edelman D, Edwards LJ, Olsen MK, Dudley TK, Harris AC, Blackwell DK, Oddone EZ.

    J Gen Intern Med. 2002 Jan;17(1):23-8.PMID: 11903772 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    How well do patients' assessments of their diabetes self-management correlate with actual glycemic control and receipt of recommended diabetes services?

    Heisler M, Smith DM, Hayward RA, Krein SL, Kerr EA.

    Diabetes Care. 2003 Mar;26(3):738-43.PMID: 12610031 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Using HbA(1c) to improve efficacy of the american diabetes association fasting plasma glucose criterion in screening for new type 2 diabetes in American Indians: the strong heart study.

    Wang W, Lee ET, Fabsitz R, Welty TK, Howard BV.

    Diabetes Care. 2002 Aug;25(8):1365-70.PMID: 12145236 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Does diabetes disease management save money and improve outcomes? A report of simultaneous short-term savings and quality improvement associated with a health maintenance organization-sponsored disease management program among patients fulfilling health employer data and information set criteria.

    Sidorov J, Shull R, Tomcavage J, Girolami S, Lawton N, Harris R.

    Diabetes Care. 2002 Apr;25(4):684-9.PMID: 11919125 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    A systematic approach to risk stratification and intervention within a managed care environment improves diabetes outcomes and patient satisfaction.

    Clark CM Jr, Snyder JW, Meek RL, Stutz LM, Parkin CG.

    Diabetes Care. 2001 Jun;24(6):1079-86.PMID: 11375374 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Adherence to American Diabetes Association standards of care by rural health care providers.

    Coon P, Zulkowski K.

    Diabetes Care. 2002 Dec;25(12):2224-9.PMID: 12453965 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening.

    Jesudason DR, Dunstan K, Leong D, Wittert GA.

    Diabetes Care. 2003 Feb;26(2):485-90.PMID: 12547886 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Impact of a program to improve adherence to diabetes guidelines by primary care physicians.

    Kirkman MS, Williams SR, Caffrey HH, Marrero DG.

    Diabetes Care. 2002 Nov;25(11):1946-51.PMID: 12401737 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Is fasting blood glucose a reliable parameter for screening for diabetes in hypertension?

    Bur A, Herkner H, Woisetschläger C, Vlcek M, Derhaschnig U, Hirschl MM.

    Am J Hypertens. 2003 Apr;16(4):297-301.PMID: 12670746 [PubMed - indexed for MEDLINE]Related articles

    12.

    Efficacy and safety profile of glimepiride in Mexican American Patients with type 2 diabetes mellitus: a randomized, placebo-controlled study.

    Luis Bautista J, Bugos C, Dirnberger G, Atherton T.

    Clin Ther. 2003 Jan;25(1):194-209.PMID: 12637120 [PubMed - indexed for MEDLINE]Related articles

    13.

    Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study.

    Guerci B, Drouin P, Grangé V, Bougnères P, Fontaine P, Kerlan V, Passa P, Thivolet Ch, Vialettes B, Charbonnel B; ASIA Group.

    Diabetes Metab. 2003 Dec;29(6):587-94.PMID: 14707887 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes.

    Buse JB, Rubin CJ, Frederich R, Viraswami-Appanna K, Lin KC, Montoro R, Shockey G, Davidson JA.

    Clin Ther. 2005 Aug;27(8):1181-95.PMID: 16199244 [PubMed - indexed for MEDLINE]Related articles

    15.

    Process measures and outcome research as tools for future improvement of diabetes treatment quality.

    Jensen T, Musaeus L, Molsing B, Lyholm B, Mandrup-Poulsen T.

    Diabetes Res Clin Pract. 2002 Jun;56(3):207-11.PMID: 11947968 [PubMed - indexed for MEDLINE]Related articles

    16.

    The glucose tolerance test, but not HbA(1c), remains the gold standard in identifying unrecognized diabetes mellitus and impaired glucose tolerance in hypertensive subjects.

    Salmasi AM, Dancy M.

    Angiology. 2005 Sep-Oct;56(5):571-9.PMID: 16193196 [PubMed - indexed for MEDLINE]Related articles

    17.

    Utility of hemoglobin A1c in predicting diabetes risk.

    Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ.

    J Gen Intern Med. 2004 Dec;19(12):1175-80.PMID: 15610327 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Development and clinical outcomes of pharmacist-managed diabetes care clinics.

    Morello CM, Zadvorny EB, Cording MA, Suemoto RT, Skog J, Harari A.

    Am J Health Syst Pharm. 2006 Jul 15;63(14):1325-31.PMID: 16809752 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.

    Derosa G, Cicero AF, D'Angelo A, Gaddi A, Ciccarelli L, Piccinni MN, Salvadeo SA, Pricolo F, Ferrari I, Gravina A, Ragonesi PD.

    Clin Ther. 2006 May;28(5):679-88. Erratum in: Clin Ther. 2006 Sep;28(9):1483. PMID: 16861090 [PubMed - indexed for MEDLINE]Related articles

    20.

    Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

    Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG.

    Clin Ther. 2008 Aug;30(8):1448-60. Erratum in: Clin Ther. 2008 Oct;30(10):1937. PMID: 18803987 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity